Tuesday, July 15, 2008
Amgen Says Bone Drug Cut Fractures in Big Trial
By MARILYN CHASE
Wall Street Journal, July 15, 2008; Page D6
In a summary of results from a big clinical trial, Amgen Inc. said its experimental bone drug shored up skeletal strength and reduced spinal fractures in men undergoing hormone-blocking treatment for prostate cancer.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment